Tirzepatide frequently causes nausea, vomiting, diarrhea, and decreased appetite, particularly during dose initiation and escalation
If a brand promises instant results, they are misleading you
doi: 10.3389/fnins.2020.601193 Received 31 August 2020 Accepted 04 November 2020 Published 08 December 2020 Volume 14 - 2020 Edited by John Zhang, Loma Linda University, United States Reviewed by Carmen Rubio, Instituto Nacional de Neurologa y Neurociruga Manuel Velasco Surez, Mexico
Hydration Tip: Take sips of cold and room-temperature water frequently rather than large gulps
The interim analysis was conducted when 50% of patients reached week 26 in the trial
As discussed in prior summaries 1 , the methodology of these epidemiologic reports is frequently flawed and does not confirm or even support a causal relationship between medicine and adverse event